Recent Press Releases

BioClinica Expands Operational Capabilities, Opens New European Offices

NEWTOWN, Pa. -- BioClinica®, Inc., the world's leading specialty clinical trial service provider, announced today the opening of new and expanded offices in London and Munich to better serve...

Ergomed Selected by Co-Development Partner Aeterna Zentaris to Conduct Confirmatory Phase 3 Clinical Trial of Macrilen™ in AGHD

Guildford, UK – 25 June 2015: Ergomed plc, (LSE: ERGO or 'Ergomed') a profitable UK-based company, dedicated to the provision of specialised services to the pharmaceutical industry and...

Novasep invests €10M to reinforce its bioconjugation services

Expansion marks Novasep's readiness for full range Antibody Drug Conjugates CMO services Pompey, France, June 25, 2015 – Novasep, a leading supplier of services and technologies for the...

PRA CONTINUES THE TRANSFORMATION OF CLINICAL TRIALS WITH PREDICTIVV

PRA Health Sciences, a leading global contract research organization, today announced its new Predictivv™ platform, the beginning of an entirely new approach on the role technology will play in...

ICON Launches Firecrest Patient Portal to Enhance Education around Informed Consent

New Firecrest Patient Portal, part of ICONIK Informatics Hub, designed to enhance patient engagement and support patient recruitment and retention. DUBLIN--ICON plc, (NASDAQ: ICLR) a global provider...

Huntingdon Life Sciences and Harlan Laboratories to become Envigo

The combined company has been created through the integration of Huntingdon Life Sciences and Harlan Laboratories, and three subsidiaries: GFA, NDA Analytics and LSR associates. Huntingdon (UK)...

PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day

BOSTON -- In conjunction with its Investor Day being held tomorrow, PAREXEL International Corporation (Nasdaq: PRXL) has updated its forward-looking guidance for the fourth quarter of Fiscal Year...

PSI CRO Moves into a New Location in the Heart of Vienna, Austria

ZUG, Switzerland--PSI CRO, a full service Contract Research Organization, known for predictable, on-time enrollment and project delivery, has expanded its presence in Austria by moving to new...

Almac Discovery Announce Ubiquitin Specific Protease Collaboration with Genentech

Craigavon, United Kingdom – Almac Discovery, a biopharmaceutical company focused on identifying and developing innovative therapeutics for the treatment of cancer, today announced a Research...

Veristat Expands Its San Francisco Bay Area Operations

HOLLISTON, Mass.--Veristat, a full service Clinical Research Organization (CRO), announced today that it has opened a new office in San Bruno, California. Located in the heart of the San Francisco...

Quintiles Unveils New Predictive and Advanced Analytics Capabilities to Enhance its Risk-Based Monitoring Solution

RESEARCH TRIANGLE PARK, N.C. – Quintiles, the world's largest biopharmaceutical services company, today announced the addition of advanced statistical monitoring and predictive analytics...

AMRI and PerkinElmer Announce Drug Discovery Collaboration as part of the Buffalo Medical Innovation and Commercialization Hub

BUFFALO, N.Y. -- As further evidence of Governor Andrew M. Cuomo's successful establishment of a dynamic and growing bio-pharma sector in Buffalo, New York, Albany Molecular Research Inc....

Recipharm Acquires OnTarget Chemistry and Extends Its Offering into Preclinical Development Services

STOCKHOLM--Regulatory News: Recipharm (STO:RECI) today announces that it has completeted the acquisition of OnTarget Chemistry in Uppsala, Sweden. OnTarget Chemistry is a fast growing CRO company...

ContraVir Pharmaceuticals Selects ImageIQ as Imaging CRO for Phase III Clinical Trial

CLEVELAND--ImageIQ, an innovative Imaging Software and Contract Research Organization for preclinical research and clinical trials, announced today that it has been chosen by ContraVir...

TFS International: TFS and LobSor Pharmaceuticals Advance Their Risk-Sharing Partnership in Parkinson's Disease to the Clinics.

LUND, Sweden--TFS and LobSor Pharmaceuticals (LobSor) have reached an important milestone in their risk-sharing partnership by advancing LobSor's LECIGel® for Advanced Parkinson's disease...

REGENXBIO Enters Into Strategic Manufacturing Collaboration With Wuxi Apptec

ROCKVILLE, Md. and SHANGHAI, China, June 11, 2015 -- REGENXBIO Inc., a leading biotechnology company in gene therapy, today announced that it has entered into an exclusive strategic manufacturing...

New Synexus Board Gears up for Expansion Through Organic Growth and Acquisition

Several of the new board members have senior management experience with pharma and CROs Synexus will broaden the number of therapy areas it offers to pharma and CROs CHORLEY, England--Following...

INC Research First CRO to Launch Site Advocacy Group to Enhance the Clinical Research Process

SAG Formed in Partnership With Society for Clinical Research Sites Leverages Site Expertise and Insights Early on in Protocol Development to Make Clinical Research More Efficient RALEIGH, N.C. --...

Eurofins strengthens its footprint in specialty clinical diagnostics with the acquisition of Diatherix Laboratories, Inc. in the US

Eurofins Scientific (EUFI.PA), the global leader in bio-analytical testing, and one of the world leaders in genomic services, announces that it has signed an agreement to acquire Diatherix...

BioClinica Names David Peters New Chief Financial Officer

NEWTOWN, Pa. -- BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced that David Peters, an accomplished senior finance and accounting executive, has...